Ministry of Health
and Family Welfare
Maharashtra, Kerala, Punjab, Tamil Nadu,
More than 1.56 cr vaccine doses administered till 7 am today
Posted On: 03 MAR
2021 12:03PM by PIB
Maharashtra,
Kerala, Punjab, Tamil Nadu,
14,989 new cases were registered in the last 24
hours.
Maharashtra, Punjab, Gujarat, Madhya Pradesh,
In percentage terms,
The Centre is continuously engaging with the States and UTs
reporting higher caseload of active cases and those reporting a spike in the
daily new COVID cases. States/UTs have been advised to maintain a continued
rigorous vigil for containing the spread of COVID-19 such the gains of
collective efforts are not squandered away. Need for effective testing,
comprehensive tracking, prompt isolation of positive cases and quick quarantine
of close contacts are strongly emphasized. The Central Government has also
rushed high-level teams to Maharashtra, Kerala, Chhattisgarh, Madhya Pradesh,
Gujarat, Punjab, Karnataka, Tamil Nadu, West Bengal, and
The graph below shows the change in active cases for
States/UTs in the last 24 hours. While Kerala, Chhattisgarh, West Bengal, Tamil
Nadu and Jammu & Kashmir show a reduction in the active cases in the last
24 hours, Maharashtra, Punjab,
Eight States, as indicated in the charts below, are
displaying an upward trajectory in daily new cases.
The 2nd dose of COVID19 vaccination started on 13th February, 2021 for those beneficiaries
who have completed 28 days after receipt of the 1st dose. Vaccination of the
FLWs started on 2nd Feb 2021.
The next phase of Covid-19 vaccination commenced from 1st March, 2021 for those who are over 60
years of age and for people aged 45 and above with specified co-morbid
conditions.
More than 1.56 cr (1,56,20,749) vaccine doses have been
administered through 3,12,188 sessions, as per the provisional report till 7 am
today. These include 67,42,187 HCWs (1st dose), 27,13,144 HCWs
(2nd dose), 55,70,230 FLWs (1st dose) and 834 FLWs (2nd Dose), 71,896 beneficiaries aged more than 45 years with
specific co-morbidities (1st Dose) and 5,22,458 beneficiaries aged more than 60 years.
|
HCWs |
FLWs |
45 to <60 years
with Co-morbidities |
Over 60 years |
Total |
||
|
1st Dose |
2nd Dose |
1st Dose |
2nd Dose |
1st Dose |
1st Dose |
|
|
67,42,187 |
27,13,144 |
55,70,230 |
834 |
71,896 |
5,22,458 |
1,56,20,749 |
As on Day-46 of the vaccination drive (2nd March, 2021), total 7,68,730 vaccine
doses were given. Out of which, 6,52,501 beneficiaries were vaccinated across
10,527 sessions for 1st dose (HCWs
and FLWs) and 1,16,229 HCWs and FLWs received 2nd dose of vaccine.
|
Date: 2nd March, 2021 |
||||||||||
|
HCWs |
FLWs |
45 to <60 years with Co-morbidities |
Over 60years |
Total Achievement |
|
|||||
|
1stDose |
2ndDose |
1stDose |
2nd Dose |
1stDose |
1stDose |
1stDose |
2ndDose |
|
||
|
37656 |
115395 |
227762 |
834 |
47617 |
339466 |
652501 |
116229 |
|
||
More than 1.08 Cr (1,08,12,044) people has recovered so far.
13,123 patients have recovered and got discharged in the last 24 hours.
86.58% of the new recovered cases are observed to be concentrated
in 6 States.
98 deaths were reported in the last 24 hours.
Four
States account for 88.78% of the new deaths.
Twenty-Four States/UTs have not reported any COVID19 deaths in
the last 24 hours. These are Madhya Pradesh,
****
MV/SJ
HFW/COVID States data/3rdMarch2021/1
(Release ID: 1702138) Visitor Counter : 174
Ministry of Health
and Family Welfare
Phase 3 Clinical Trial of COVAXIN, developed by ICMR
& Bharat Biotech, shows 81% efficacy
The results, evaluated by an independent data safety and monitoring board, show
that the vaccine is well-tolerated and efficacious against SARS-CoV-2 across a
wide range of age groups and variants in the country
Posted On: 03 MAR
2021 6:30PM by PIB
Phase
3 results of the COVAXIN, developed by Indian Council of Medical Research
(ICMR)in partnership with Bharat BiotechInternational Limited (BBIL),has shown
an interim vaccine efficacy of 81% in preventing Covid-19.
The
Phase 3 trial,jointly initiated by ICMR and BBIL in mid-November 2020,was
conducted in a total of 25,800 individualsacross 21 sites. The interim efficacy
trend of 81%, analyzed as per the protocol approved by the DCGI, putsit at par
with other global front-runner vaccines.
“The
bench-to-bedside journey of completely indigenous COVID-19 vaccine in less than
8 months’ time showcases the immense strength of Atmanirbhar Bharat[self-reliant
The
COVAXIN is the first COVID-19 vaccine that has been developed completely in
Pre-clinical
studies in small animals and hamsters showed promising results in terms of
safety and immunogenicity. Further studies conducted in rhesus macaques also
established remarkable safety and protective efficacy of COVAXIN. Phase 1 and Phase 2 clinical
trialsconducted in 755 participants demonstrated high safety profile of the
candidate vaccine withseroconversion rates of 98.3% and 81.1%on day 56 and
104respectively.
COVAXIN
has been developed on the WHO prequalifiedverocell platform, which is globally
recognized with a well-established track record of safety. COVAXIN’s ability to neutralize
“The development and deployment of
COVAXIN ensures that
|
Bench-to-Bedside
Journey of COVAXIN: Bharat kiApni Vaccine ·
March 11, 2020: When COVID-19
was declared a pandemic by the World Health Organization (WHO), ·
March 13, 2020: ICMR-National
Institute of Virology (ICMR-NIV) successfully isolates the SARS-CoV-2 virus. ·
April 2020: ICMR enters in a
public-private partnership with Bharat Biotech International Ltd (BBIL) for
developing an effective vaccine candidate for SARS-CoV-2. ·
May 2020: ICMR-NIV transfers the
virus strain to BBIL and characterizes the vaccine developed by BBIL through
in-vitro experiments and electron microscopy studies. ·
June-August 2020: Experiments in small
animals (mouse, rats and rabbits) and hamsters established promising safety
and immunogenicity of COVAXIN. Data has been published by highly reputed
journal of the Cell Press. (Link to research papers: Link 1, Link 2) ·
July-August 2020: Studies
conducted in rhesus macaques established safety and protective efficacy of
COVAXIN. The results established remarkable ability of the vaccine candidate
to clear the virus from infected organs along with its capacity to ·
July-October 2020:Phase 1
and 2 clinical trials conducted in 755 participants demonstrated high safety
profile of the candidate vaccine alongwithseroconversion rates of 98.3% and
81.1% respectively on day 56 and 104 respectively. The results are published in
Lancet journal. Link to research paper: Link 4, Link 5 ·
November 2020: The largest
ever clinical trial for COVID-19 in ·
January 3, 2021:Drugs
Controller General of India (DCGI) providesapproval for Restricted Use in
Emergency Situations for COVAXIN ·
January 16, 2021: ·
January 27, 2021:COVAXIN’s
ability to neutralize ·
March 3, 2021: Interim
results of Phase 3 efficacy trials of COVAXINshow 81% efficacy against
SARS-CoV-2virus. The follow-up of participants in the trial is still ongoing. |
About ICMR: The
Indian Council of Medical Research (ICMR), New Delhi, is the apex body in India
for the formulation, coordination and promotion of biomedical research, is one
of the oldest medical research bodies in the world. ICMR’s research priorities
align with the National health priorities. These efforts are undertaken with a
view to reduce the total burden of disease and to promote health and well-being
of the population. ICMR promotes biomedical research in the country through
intramural as well as extramural research. Visit us at https://www.icmr.gov.in/
Contacts
Dr
Nivedita Gupta
Scientist
F, Epidemiology and Communicable Diseases Division, ICMR
Email: drguptanivedita@gmail.com
Media Coordinator
Dr Lokesh
Sharma
Scientist E
Indian
Council of Medical Research
M:
+917567311014
****
MV/SJ
(Release ID: 1702293) Visitor Counter : 29
Ministry of Health
and Family Welfare
Observing World Hearing Day
Dr Harsh Vardhan releases WHO’s World Report on Hearing
“National Programme for Prevention and Control of Deafness will target over 6%
of
Posted On: 03 MAR
2021 6:28PM by PIB
On the World Hearing Day,Dr Harsh Vardhan, Union Minister for
Health and Family Welfare as Chairman of Executive Board of WHO released WHO’s World Report on Hearing.
To underscore the importance of ear health, Dr Harsh Vardhan
referred to a 2018 WHO report which observed that 2% of
He informed the audience on India’s recently concluded study
on hearing loss and its causes in our population: “A multi – centric
cross-sectional survey conducted as per the WHO recommended Probability
Proportional to Size (PPS) sampling technique assessed 92,097 people in the
community across 6 sites in India. Age-appropriate audiological testing as per
WHO norms including pure tone audiometry, tympanometry, oto-acoustic emissions,
behavioral observation audiometry and ENT examination were all undertaken
onsite in a specially designed sound treated audiological bus.” The sample size
makes this the world’s largest such study to-date.
The results have showed a changing profile of hearing loss in
Dr. Harsh Vardhan showcased
Dr. Harsh Vardhan also informed the audience that with the
COVID pandemic abating in
· By improving services at
community and primary levels through training of health workers for task
sharing, in line with the strategies outlined in the report.
· Expanding access to
affordable hearing technologies for all those in need.
· Using the power of
Information Technology (IT) to raise awareness among our youth on safe
listening as a means of hearing loss prevention.
Dr.
Tedros Adhanom Ghebreyesus, Director-General, WHO, Dr. Bente Mikkelsen,
Director, Department of Non communicable Diseases, WHO, Dr. Gaya
ManoriGamberawi, Head of Learning & Capacity Development,Health Emergencies
Programme, WHO, Dr Shelly Chadha, Lead Officer, WHO programme for ear and
hearing care and other senior officials of WHO attended the event.
****
MV/SJ
(Release ID: 1702290) Visitor Counter : 19
Ministry of Health
and Family Welfare
On World Hearing Day, Dr. Harsh Vardhan virtually
inaugurates 6 new ‘Outreach Service Centers for Communication Disorders’ across
the country by AIISH, Mysuru
Those who oppose blaring noise and sounds beyond 10 pm in the night are aware
of the grave danger this persistent noise has on the ear health of everyone-
Dr. Harsh Vardhan
“Newborn screening, school screening and sensitization programs for general
public about different communication disorders, early identification &
intervention should be included in the outreach activities”
Posted On: 03 MAR
2021 4:54PM by PIB
Dr Harsh Vardhan, Union Minister for Health and Family
Welfare today virtually inaugurated six new ‘Outreach Service Centers for
Communication Disorders’ across the country byAll India
Institute of Speech and Hearing (AIISH), Mysuru on the occasion of World Hearing Day in the presence of
ShriAshwini Kumar Choubey, Minister of State, Ministry of Health and Family Welfare.
The
new six Outreach Service Centres are:
1. Indira Gandhi Institute
of Medical Science,
2. Bidar Institute of
Medical Sciences, Bidar, Karnataka
3. Belagavi Institute of
Medical Sciences, Belagavi, Karnataka
4. Karnataka Institute of
Medical Science, Hubbali, Karnataka
5. AIIMS,
6.
Dr.
Harsh Vardhan also released the report by ICMR-AIIMS and a Pictorial guidebook
on “Prevent Hearing Loss” by DGHS-PGIMER.
Expressing
his appreciation, Dr Vardhan congratulated AIISH for launching six new
‘Outreach Service Centres for Communication Disorders’ across the country. The
Union Minister said, “ The number of individuals existing with such disorders
and the lack of professionals and specialists to cater the need for this
population warrants the need for initiation of Outreach Service Centers in the
hospitals across the country." He added, “We should aim to reach out to
the underserved and unserved areas in the country to cater to the needs of
individuals with communication disorders. This will enable early identification
and diagnosis of communication disorder and early intervention, thereby
preventing further deficits in speech, language and cognition and facilitating
the overall development of the child.”
Dr. Harsh Vardhan said, “This is a very important day for me
personally. Good hearing and communication are important at
all stages of life. Timely action is needed to prevent and address hearing loss
across the life course.I have seen and understood people with communication
disorder from my medical days. Communication disorder not only affects the individual,
but can have far-reaching effects on the entire family. When these uncommon,
unrecognized disabilities go undiagnosed and unmanaged, they can have a
significant detrimental effect on the overall development. It becomes very
important to raise awareness on how to prevent deafness and hearing loss and
promote ear and hearing care across the world.”
Emphasizing
on the need for early identification and early intervention to control and
manage communication disorders, the Union Minister said, “Hearing impairment
can lead to poor speech and language development in children. This can in turn
affect their overall development of communication.However, if these are
identified early and early intervention is initiated, it will reduce the
negative consequences of the disorder.”
He
further commented on the lack of awarenessregarding the early signs and
treatment among general public. He said, “People are often unaware about the
need for early screening and treatments available for communication
disorder.Parents are often inexperienced about hearing disability at an early
age. Looking at the current data available, there is an urgent need to prevent
the occurrence of these communication disorders by taking appropriate measures
through strategies likepublic education, early detection followed by early and
continued intervention to restore effective functioning.”
He
added, “Newborn screening, school screening and sensitization programs for
general public about different communication disorders, need for early
identification & intervention should be included as a part of the outreach
activity to promote early identification and early intervention of
Communication disorders.”
The
Union Minister also raised awareness about the dangers of continuous loud noise
and the impact it can have on the ocular health of people. Speaking on noise
induced hearing loss, Dr. Harsh Vardhan said, “This is a sensitive issue and we
should work on it. Those who oppose blaring noise and sounds beyond 10 pm in
the night are aware of the grave danger this persistent noise has on the ear
health of everyone.”
Shri
Ashwini Kumar Choubey said, “I express my happiness on the occasion of World
Hearing Day and on this launch of the Outreach Service centers.
Shri Mangal Pandey, Health Minister, Bihar;Shri.Rajesh
Bhushan, Secretary, MoHFW; Ms. Vandana Gurnani, Addl. Secretary; Shri.Vishal
Chauhan, Joint Secretary; Dr. Kanwar Sen, Addl. DGHS; Dr. Alok Thakkar, HOD
(ENT) AIIMS, New Delhi; Prof. M. Pushpavathi, Director, AIISH, Mysuru; and Dr Arun Kumar Agarwal, former Dean Maulana Azad Medical College were
present at the event.
****
MV/SJ
(Release ID: 1702239) Visitor Counter : 54
No comments:
Post a Comment